The benefit of extending clopidogrel treatment beyond the 12-month period recommended in current guidelines after myocardial infarction (MI) is debated. We analysed the risk of adverse cardiovascular outcomes after discontinuation of 12 months of clopidogrel treatment.
|Journal||European Heart Journal (English Edition)|
|Number of pages||8|
|Publication status||Published - 2012|